05.29.25 -- How Close Is The First FDA-Approved Full-Spectrum Botanical Drug For Autism?

By fostering a culture of continuous improvement through internal audits, clinical research sites can identify non-compliance issues and enhance their research practices.

The use of AI in pharmacovigilance can enhance processes such as data analysis, signal detection, and case management by increasing efficiency, accuracy, and the ability to manage large datasets.

When faced with industry pressures, companies seek out essential support to ensure their product's market plan is grounded in expert guidance.

We share important factors to consider when weighing your contract service provider options. These “Three Cs” can indicate whether a service provider has the capabilities desired by a drug sponsor.

The willingness to seek expert support from Rescue CROs when clinical trials face critical challenges is not a sign of weakness but a demonstration of accountability and commitment to excellence.

Discover when life sciences organizations should develop technology in-house, buy off-the-shelf solutions, or form strategic partnerships, exploring the costs and risks that come with each approach.

In the rapidly evolving landscape of drug development, Contract Research Organizations (CROs) play a pivotal role. Learn more about CRO and selecting the right one to partner with.

Leveraging over 140 completed neuroscience studies and specialized knowledge in neurodegenerative diseases, TFS delivers substantial expertise and a demonstrated history of successful trials.

Our extensive network of specialized Healthcare-First psychiatry research sites is dedicated to advancing psychiatric care through cutting-edge clinical studies.